订阅小程序
旧版功能

RATIONALE-307: Updated Biomarker Analysis of Phase 3 Study of Tislelizumab Plus Chemo vs Chemo Alone For 1L Advanced Sq-NSCLC

J. Wang,S. Lu,Z. Wang,C. Hu,Y. Sun,K. Yang,M. Chen,J. Zhao,L. Liang,Y. Huo, Y. Zhang, R. Huang, X. Wu, X. Ma,S. J. Leaw,F. Bai, Z. Shen

JOURNAL OF THORACIC ONCOLOGY（2021）

引用 4|浏览29
关键词
pd-1 inhibitor,immunotherapy,biomarkers
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要